NCT04096014View on ClinicalTrials.gov

Late Evening and Early Morning Protein Supplement to Reduce Readmissions for Hepatic Encephalopathy

NARecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 16, 2019

Primary Completion Date

June 30, 2026

Study Completion Date

October 30, 2026

Conditions
Hepatic Encephalopathy
Interventions
DIETARY_SUPPLEMENT

Ensure Enlive

The subjects in the intervention group will receive two Ensure Enlive supplements per day for 180 days.

OTHER

Standard Of Care

The subjects in the Standard of care group will continue to receive the standard clinical therapy.

Trial Locations (1)

44195

RECRUITING

Cleveland Clinic Foundation, Cleveland

All Listed Sponsors
lead

The Cleveland Clinic

OTHER